Adjuvant clinical effects of polydeoxyribonucleotide in lichen sclerosus
Copyright policy )Adjuvant clinical effects of polydeoxyribonucleotide in lichen sclerosus
ejd.2012.1769 Auteur(s) : Luigi Laino laino@ifo.it Dermatological Insitute San Gallicano – IRCCS, Via Elio Chianesi 53 00144 Rome, Italy We report a group of 18 individuals (12 males, 6 females, aged 22 to 64 years) suffering from mild to severe genital lichen sclerosus (LS). All patients had a history of unresponsiveness or slight improvement to potent topical steroid (clobetasol 17-propionate 0.05%). The patients were evaluated in compliance with the recent guidelines of the British Association [...]
Adult, Male, Middle Aged, Young Adult, Lichen Sclerosus et Atrophicus, Polydeoxyribonucleotides, Humans, Drug Therapy, Combination, Female, Genital Diseases, Male, Genital Diseases, Female
Adult, Male, Middle Aged, Young Adult, Lichen Sclerosus et Atrophicus, Polydeoxyribonucleotides, Humans, Drug Therapy, Combination, Female, Genital Diseases, Male, Genital Diseases, Female
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).5 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!